vaccinetracker.ecdc.europa.eu
Open in
urlscan Pro
88.131.255.91
Public Scan
Submitted URL: http://88.131.255.91/
Effective URL: https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html
Submission: On November 22 via manual from PT — Scanned from DE
Effective URL: https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html
Submission: On November 22 via manual from PT — Scanned from DE
Form analysis
3 forms found in the DOM<form id="dataExportForm" class="ng-pristine ng-valid">
<div class="modal-body">
<div class="form-group row">
<label for="dataFormat" class="col-sm-3 col-form-label">Format</label>
<div id="dataFormat" class="col-sm-9 btn-group" role="group">
<button id="dataFormatCsv" type="button" class="qcmd btn btn-outline-covid-primary active">CSV</button>
<button id="dataFormatXml" type="button" class="qcmd btn btn-outline-covid-primary">XML</button>
<button id="dataFormatJson" type="button" class="qcmd btn btn-outline-covid-primary">JSON</button>
</div>
</div>
</div>
<div class="modal-footer">
<button class="qcmd btn btn-covid-secondary" data-dismiss="modal">Close</button>
<button class="qcmd btn btn-covid-primary" type="submit">Export</button>
</div>
</form>
<form id="bookmarkForm" class="ng-pristine ng-valid">
<div class="modal-body">
<div class="form-group row">
<label for="bmtitle" class="col-sm-3 col-form-label">Title</label>
<div class="col-sm-9"><input type="text" id="bmtitle" class="qcmd form-control" required=""></div>
</div>
<div class="form-group row">
<label for="bmdesc" class="col-sm-3 col-form-label">Description</label>
<div class="col-sm-9"><input type="text" id="bmdesc" class="qcmd form-control"></div>
</div>
</div>
<div class="modal-footer">
<button class="qcmd btn btn-covid-secondary" data-dismiss="modal">Close</button>
<button class="qcmd btn btn-covid-primary" type="submit">Create</button>
</div>
</form>
<form id="exportForm" class="ng-pristine ng-valid">
<div class="modal-body">
<div id="exportType" class="form-group">
<div class="form-check">
<input class="form-check-input" type="radio" name="exportType" id="exportData" value="data" checked="">
<label class="form-check-label" for="exportData">Export data</label>
</div>
<div class="form-check">
<input class="form-check-input" type="radio" name="exportType" id="exportImg" value="img">
<label class="form-check-label" for="exportImg">Export as an image</label>
</div>
<!--
<div class="form-check">
<input class="form-check-input" type="radio" name="exportType" id="exportPdf" value="pdf">
<label class="form-check-label" for="exportPdf">Export to pdf</label>
</div>
-->
</div>
<div id="exportImgSettings" class="form-group hidden">
<div class="form-group row" style="display:none">
<label for="imgSize" class="col-sm-3 col-form-label">Image size</label>
<div id="imgSize" class="col-sm-9 btn-group" role="group">
<button id="imgSizeCurrent" type="button" class="qcmd btn btn-outline-covid-primary active">Default</button>
<button id="imgSizeCustom" type="button" class="qcmd btn btn-outline-covid-primary">Custom</button>
</div>
</div>
<div class="form-group row">
<label for="imgSizeWidth" class="col-sm-3 col-form-label">Width (pixels)</label>
<div class="col-sm-9"><input type="number" min="0" id="imgSizeWidth" class="qcmd form-control"></div>
</div>
<div class="form-group row">
<label for="imgSizeHeight" class="col-sm-3 col-form-label">Height (pixels)</label>
<div class="col-sm-9"><input type="number" min="0" id="imgSizeHeight" class="qcmd form-control"></div>
</div>
<div class="form-group row">
<label for="imgTypeSelect" class="col-sm-3 col-form-label">File type</label>
<div class="col-sm-9"><select id="imgTypeSelect" class="qcmd form-control">
<option value="PNG" selected="">Png</option>
<option value="JPG">Jpeg</option>
</select></div>
</div>
</div>
<div id="exportPdfSettings" class="form-group hidden">
<div class="form-group row">
<label for="paperSizeSelect" class="col-sm-3 col-form-label">Paper size</label>
<div class="col-sm-9"><select id="paperSizeSelect" class="qcmd form-control">
<option value="A3">A3</option>
<option value="A4" selected="">A4</option>
<option value="A5">A5</option>
<option value="A6">A6</option>
<option value="A7">A7</option>
<option value="custom">Custom</option>
</select></div>
</div>
<div class="form-group row">
<label for="paperSizeWidth" class="col-sm-3 col-form-label">Width (mm)</label>
<div class="col-sm-9"><input type="number" min="0" id="paperSizeWidth" class="qcmd form-control" disabled=""></div>
</div>
<div class="form-group row">
<label for="paperSizeHeight" class="col-sm-3 col-form-label">Height (mm)</label>
<div class="col-sm-9"><input type="number" min="0" id="paperSizeHeight" class="qcmd form-control" disabled=""></div>
</div>
<div class="form-group row">
<label for="pdfOrientation" class="col-sm-3 col-form-label">Orientation</label>
<div id="pdfOrientation" class="col-sm-9 btn-group" role="group">
<button id="pdfOrientationPortrait" type="button" class="qcmd btn btn-outline-covid-primary">Portrait</button>
<button id="pdfOrientationLandscape" type="button" class="qcmd btn btn-outline-covid-primary active">Landscape</button>
</div>
</div>
<div class="form-group row">
<label for="pdfAspectRatio" class="col-sm-3 col-form-label">Aspect ratio</label>
<div id="pdfAspectRatio" class="col-sm-9 btn-group" role="group">
<button id="pdfAspectRatioCurrent" type="button" class="qcmd btn btn-outline-covid-primary">Default size</button>
<!--button id="pdfAspectRatioCustom" type="button" class="qcmd btn btn-outline-covid-primary">Custom size</button-->
<button id="pdfAspectRatioFitPage" type="button" class="qcmd btn btn-outline-covid-primary active">Fit to page</button>
</div>
</div>
<div class="form-group row hidden">
<label for="objSizeWidth" class="col-sm-3 col-form-label">Width (pixels)</label>
<div class="col-sm-9"><input type="number" min="0" id="objSizeWidth" class="qcmd form-control" disabled=""></div>
</div>
<div class="form-group row hidden">
<label for="objSizeHeight" class="col-sm-3 col-form-label">Height (pixels)</label>
<div class="col-sm-9"><input type="number" min="0" id="objSizeHeight" class="qcmd form-control" disabled=""></div>
</div>
</div>
</div>
<div class="modal-footer">
<button class="qcmd btn btn-covid-secondary" data-dismiss="modal">Close</button>
<button class="qcmd btn btn-covid-primary" type="submit">Export</button>
</div>
</form>
Text Content
Manage cookies COOKIES We use cookies to collect statistics on how the visitors navigate the website and to improve the user experience. Find out more on how we use cookies and how you can change your settings. I accept cookies I don't accept cookies Remind me later EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL COVID-19 VACCINE TRACKER * Reset selections * Help * Mobile version Open data Vaccine Tracker Weekly country overviews ECDC-WHO COVID-19 Explorer * * Key Figures * Vaccine Uptake * Age Groups * Doses by Product * Country Profiles * Notes on the data * Help Disclaimer: the information presented in the ECDC Vaccine Tracker is based on data reported by EU/EEA countries to the European Surveillance System (TESSy). EU/EEA countries are requested to report data every two weeks on Tuesdays. The data in the tracker are refreshed every two weeks on Thursdays at 11h after validation at ECDC level. Considering this reporting timeframe and the time ECDC needs to process the data, some discrepancies may be observed between the figures published by ECDC and the ones presented in official national reports or web sites. Users are advised to use all data with caution and be aware of their limitations. Data for the current week are preliminary, as countries may be uploading only partial data. All data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed. Please refer to the "Notes on the data" tab for additional information. Key figures of the COVID-19 vaccine rollout Country: Reporting Week: Country figures EU EU/EEA NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS This refers to the total cumulative number of doses of any vaccine product distributed by manufacturers to EU/EEA countries. NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES PER HUNDRED INHABITANTS This refers to the total number of vaccine doses distributed by manufacturers to EU/EEA countries divided by the size of the total population in each country. Population denominators for the total population are obtained from Eurostat/UN. NUMBER OF VACCINE DOSES ADMINISTERED This refers to the total number of doses of any vaccine product administered in EU/EEA countries. CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES This refers to the cumulative uptake of a complete primary course with any vaccine product and is presented for the total population, adults (18+), people aged 60 years and above (60+) and children below 18 years. It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the first booster dose and is presented for the total population, adults (18+) and people aged 60 years and above (60+). See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the second booster dose and is presented for the total population, adults (18+) and people aged 60 years and above (60+). See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. NUMBER OF VACCINE DOSES ADMINISTERED This refers to the total number of doses of any vaccine product administered in EU/EEA countries. CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES This refers to the cumulative uptake of at least one vaccine dose of any vaccine product and is presented for the total population and adults (18+). It is calculated as follows: number of first doses cumulatively administered divided by the size of the population The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES This refers to the cumulative uptake of a complete primary course with any vaccine product and is presented for the total population and adults (18+). It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the first booster dose and is presented for the total population and adults (18+). See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the second booster dose and is presented for the total population and adults (18+). See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. Please refer to the notes on the data tab for additional information on the data Data as of 2022-11-17 Disclaimer: the information presented in the ECDC Vaccine Tracker is based on data reported by EU/EEA countries to the European Surveillance System (TESSy). EU/EEA countries are requested to report data every two weeks on Tuesdays. The data in the tracker are refreshed every two weeks on Thursdays at 11h after validation at ECDC level. Considering this reporting timeframe and the time ECDC needs to process the data, some discrepancies may be observed between the figures published by ECDC and the ones presented in official national reports or web sites. Users are advised to use all data with caution and be aware of their limitations. Data for the current week are preliminary, as countries may be uploading only partial data. All data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed. Please refer to the "Notes on the data" tab for additional information. Total doses distributed to EU/EEA countries 29 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden KPI Kein Titel 1,352,615,905 KPI Kein Titel 950,861,692 Total doses administered in EU/EEA countries 30 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden Indicator: Variable input Kein Titel Uptake one doseUptake primary courseUptake first boosterUptake second boosterNumber of first doses administeredNumber of primary courses administeredNumber of first boosters administeredNumber of second boosters administered Country: SimpleFieldSelect Kein Titel All EU/EEA countriesAustriaBelgiumBulgariaCroatiaCyprusCzechiaDenmarkEstoniaFinlandFranceGermanyGreeceHungaryIcelandIrelandItalyLatviaLiechtensteinLithuaniaLuxembourgMaltaNetherlandsNorwayPolandPortugalRomaniaSlovakiaSloveniaSpainSweden Adults 18+ Adults 60+ Total Population EU EU/EEA Karte CUMULATIVE UPTAKE (%) OF THE PRIMARY COURSE IN THE TOTAL POPULATION IN EU/EEA COUNTRIES AS OF 2022-11-17 © EuroGeographics © UN–FAO © Turkstat CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES This refers to the cumulative uptake of at least one vaccine dose of any vaccine product. It is calculated as follows: number of first doses cumulatively administered divided by the size of the population The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES This refers to the cumulative uptake of a complete primary course with any vaccine product. It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the first booster dose. See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the second booster dose. See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. NUMBER OF FIRST DOSES ADMINISTERED The number of first doses administered is cumulative and it refers only to the total number of vaccine doses administered as first dose of 2-dose vaccination course products. NUMBER OF PRIMARY COURSES ADMINISTERED The number of complete primary courses administered is cumulative and it refers to the total number of primary courses administered defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen). NUMBER OF BOOSTER DOSES ADMINISTERED The number of booster doses administered is cumulative and based on the definition of first and second boosters described above. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to the Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. VT-Kpi-Text CUMULATIVE VACCINE UPTAKE (%) IN THE TOTAL POPULATION IN EU/EEA COUNTRIES One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% Sammelbox Kein Titel Leere Sammelbox Liniendiagramm CUMULATIVE VACCINE UPTAKE (%) IN THE TOTAL POPULATION IN EU/EEA COUNTRIES AS OF 2022-11-17 BY REPORTING WEEK (DATA FOR THE CURRENT WEEK ARE PRELIMINARY) At least one doseAt least one dosePrimary coursePrimary courseFirst boosterFirst boosterSecond boosterSecond booster CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES This refers to the cumulative uptake of at least one vaccine dose of any vaccine product. It is calculated as follows: number of first doses cumulatively administered divided by the size of the population The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES This refers to the cumulative uptake of a complete primary course with any vaccine product. It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the first booster dose. See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the second booster dose. See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to the Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. VT-Kpi-Text NUMBER OF PEOPLE VACCINATED IN THE TOTAL POPULATION IN EU/EEA COUNTRIES One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second booster 49,937,331 Sammelbox Kein Titel Leere Sammelbox Balkendiagramm CUMULATIVE NUMBER OF VACCINE DOSES ADMINISTERED TO THE TOTAL POPULATION IN EU/EEA COUNTRIES AS OF 2022-11-17 BY REPORTING WEEK (DATA FOR CURRENT WEEK ARE PRELIMINARY) First dosesFirst dosesPrimary coursesPrimary coursesFirst boostersFirst boostersSecond boostersSecond boostersUnspecified dosesUnspecified doses NUMBER OF FIRST DOSES ADMINISTERED The number of first doses administered is cumulative and it refers only to the total number of vaccine doses administered as first dose of 2-dose vaccination course products. NUMBER OF PRIMARY COURSES ADMINISTERED The number of complete primary courses administered is cumulative and it refers to the total number of primary courses administered defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen). NUMBER OF BOOSTER DOSES ADMINISTERED The number of booster doses administered is cumulative and based on the following definition of first and second boosters. First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to the Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. Variable input Kein Titel Weekly dosesCumulative doses Please refer to the notes on the data tab for additional information on the data Data as of 2022-11-17 Disclaimer: the information presented in the ECDC Vaccine Tracker is based on data reported by EU/EEA countries to the European Surveillance System (TESSy). EU/EEA countries are requested to report data every two weeks on Tuesdays. The data in the tracker are refreshed every two weeks on Thursdays at 11h after validation at ECDC level. Considering this reporting timeframe and the time ECDC needs to process the data, some discrepancies may be observed between the figures published by ECDC and the ones presented in official national reports or web sites. Users are advised to use all data with caution and be aware of their limitations. Data for the current week are preliminary, as countries may be uploading only partial data. All data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed. Please refer to the "Notes on the data" tab for additional information. Total doses distributed to EU/EEA countries 29 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden Total doses administered in EU/EEA countries 30 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden Indicator: Target Group: Country: EU EU/EEA CUMULATIVE VACCINE UPTAKE AMONG PEOPLE AGED 60 YEARS AND ABOVE IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to individuals aged 60 years and above divided by the size of the corresponding population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of booster/additional doses below. Population denominators for total population and age-specific population are obtained from Eurostat/UN. CUMULATIVE VACCINE UPTAKE AMONG HEALTHCARE WORKERS IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to healthcare workers (HCW) divided by the size of the population of HCW as reported by the countries. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of booster/additional doses below. CUMULATIVE VACCINE UPTAKE AMONG RESIDENTS IN LONG-TERM CARE FACILITIES IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to residents in long-term care facilities (LTCF) divided by the size of the population of LTCF residents as reported by the countries. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of additional doses below. NUMBER OF FIRST DOSES ADMINISTERED The number of first doses administered is cumulative and it refers to the total number of vaccine doses administered to adults (18+) or to the total population only as first dose of 2-dose vaccination course products (i.e. single doses of Janssen vaccine not included). NUMBER OF PRIMARY COURSES ADMINISTERED The number of primary courses administered is cumulative and it refers to the total number of primary courses administered to adults (18+) or to the total population. Primary course is defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen). NUMBER OF BOOSTER/ADDITIONAL DOSES ADMINISTERED The number of booster and additional doses administered is cumulative and it refers to vaccine doses either administered as a booster dose to individuals who already received a complete primary course or as an additional dose as extension of the primary course in certain population groups (e.g. in immunocompromised individuals). Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to the Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. CUMULATIVE VACCINE UPTAKE AMONG PEOPLE AGED 60 YEARS AND ABOVE IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to individuals aged 60 years and above divided by the size of the corresponding population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of booster/additional doses below. Population denominators for total population and age-specific population are obtained from Eurostat/UN. CUMULATIVE VACCINE UPTAKE AMONG HEALTHCARE WORKERS IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to healthcare workers (HCW) divided by the size of the population of HCW as reported by the countries. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of booster/additional doses below. CUMULATIVE VACCINE UPTAKE AMONG RESIDENTS IN LONG-TERM CARE FACILITIES IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to residents in long-term care facilities (LTCF) divided by the size of the population of LTCF residents as reported by the countries. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of additional doses below. NUMBER OF FIRST DOSES ADMINISTERED The number of first doses administered is cumulative and it refers to the total number of vaccine doses administered to adults (18+) or to the total population only as first dose of 2-dose vaccination course products (i.e. single doses of Janssen vaccine not included). NUMBER OF PRIMARY COURSES ADMINISTERED The number of primary courses administered is cumulative and it refers to the total number of primary courses administered to adults (18+) or to the total population. Primary course is defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen). NUMBER OF BOOSTER/ADDITIONAL DOSES ADMINISTERED The number of booster and additional doses administered is cumulative and it refers to vaccine doses either administered as a booster dose to individuals who already received a complete primary course or as an additional dose as extension of the primary course in certain population groups (e.g. in immunocompromised individuals). Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to the Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. CUMULATIVE VACCINE UPTAKE AMONG PEOPLE AGED 60 YEARS AND ABOVE IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to individuals aged 60 years and above divided by the size of the corresponding population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of booster/additional doses below. Population denominators for total population and age-specific population are obtained from Eurostat/UN. CUMULATIVE VACCINE UPTAKE AMONG HEALTHCARE WORKERS IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to healthcare workers (HCW) divided by the size of the population of HCW as reported by the countries. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of booster/additional doses below. CUMULATIVE VACCINE UPTAKE AMONG RESIDENTS IN LONG-TERM CARE FACILITIES IN EU/EEA COUNTRIES These figures display the cumulative vaccine uptake (presented separately for at least one dose, a complete primary course and a booster/additional dose) that is calculated as follows: number of first doses, primary courses or booster/additional doses, cumulatively administered to residents in long-term care facilities (LTCF) divided by the size of the population of LTCF residents as reported by the countries. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. See definition of additional doses below. NUMBER OF FIRST DOSES ADMINISTERED The number of first doses administered is cumulative and it refers to the total number of vaccine doses administered to adults (18+) or to the total population only as first dose of 2-dose vaccination course products (i.e. single doses of Janssen vaccine not included). NUMBER OF PRIMARY COURSES ADMINISTERED The number of primary courses administered is cumulative and it refers to the total number of primary courses administered to adults (18+) or to the total population. Primary course is defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen). NUMBER OF BOOSTER/ADDITIONAL DOSES ADMINISTERED The number of booster and additional doses administered is cumulative and it refers to vaccine doses either administered as a booster dose to individuals who already received a complete primary course or as an additional dose as extension of the primary course in certain population groups (e.g. in immunocompromised individuals). Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to the Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. Please refer to the notes on the data tab for additional information on the data Data as of 2022-11-17 Disclaimer: the information presented in the ECDC Vaccine Tracker is based on data reported by EU/EEA countries to the European Surveillance System (TESSy). EU/EEA countries are requested to report data every two weeks on Tuesdays. The data in the tracker are refreshed every two weeks on Thursdays at 11h after validation at ECDC level. Considering this reporting timeframe and the time ECDC needs to process the data, some discrepancies may be observed between the figures published by ECDC and the ones presented in official national reports or web sites. Users are advised to use all data with caution and be aware of their limitations. Data for the current week are preliminary, as countries may be uploading only partial data. All data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed. Please refer to the "Notes on the data" tab for additional information. Total doses distributed to EU/EEA countries 29 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden Total doses administered in EU/EEA countries 30 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden Indicator: Country: EU EU/EEA CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES This refers to the cumulative uptake of at least one vaccine dose of any vaccine product and is presented by age group. It is calculated as follows: number of first doses cumulatively administered divided by the size of the population The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18. CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES This refers to the cumulative uptake of a complete primary course with any vaccine product and is presented by age group. It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18. CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the first booster dose and is presented by age group. See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18. First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the second booster dose and is presented by age group. See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18. Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. NUMBER OF FIRST DOSES ADMINISTERED The number of first doses administered is cumulative and it refers only to the total number of vaccine doses administered as first dose of 2-dose vaccination course products. NUMBER OF PRIMARY COURSES ADMINISTERED The number of complete primary courses administered is cumulative and it refers to the total number of primary courses administered defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen). NUMBER OF BOOSTER DOSES ADMINISTERED The number of booster doses administered is cumulative and based on the definition of first and second boosters described above. PROPORTION OF VACCINE DOSES ADMINISTERED BY AGE GROUP This graph shows the proportion of vaccine doses administered overall (as first, second, booster or unspecified dose) by age group out of the total number of doses administered. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES This refers to the cumulative uptake of at least one vaccine dose of any vaccine product and is presented by age group. It is calculated as follows: number of first doses cumulatively administered divided by the size of the population The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18. CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES This refers to the cumulative uptake of a complete primary course with any vaccine product and is presented by age group. It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18. CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the first booster dose and is presented by age group. See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18. First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the second booster dose and is presented by age group. See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18. Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. NUMBER OF FIRST DOSES ADMINISTERED The number of first doses administered is cumulative and it refers only to the total number of vaccine doses administered as first dose of 2-dose vaccination course products. NUMBER OF PRIMARY COURSES ADMINISTERED The number of complete primary courses administered is cumulative and it refers to the total number of primary courses administered defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen). NUMBER OF BOOSTER DOSES ADMINISTERED The number of booster doses administered is cumulative and based on the definition of first and second boosters described above. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES This refers to the cumulative uptake of at least one vaccine dose of any vaccine product and is presented by age group. It is calculated as follows: number of first doses cumulatively administered divided by the size of the population The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES This refers to the cumulative uptake of a complete primary course with any vaccine product and is presented by age group. It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN. CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the first booster dose and is presented by age group. See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES This refers to the cumulative uptake of the second booster dose and is presented by age group. See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. NUMBER OF FIRST DOSES ADMINISTERED The number of first doses administered is cumulative and it refers only to the total number of vaccine doses administered as first dose of 2-dose vaccination course products. NUMBER OF PRIMARY COURSES ADMINISTERED The number of complete primary courses administered is cumulative and it refers to the total number of primary courses administered defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen). NUMBER OF BOOSTER DOSES ADMINISTERED The number of booster doses administered is cumulative and based on the definition of first and second boosters described above. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. Please refer to the notes on the data tab for additional information on the data Data as of 2022-11-17 Disclaimer: the information presented in the ECDC Vaccine Tracker is based on data reported by EU/EEA countries to the European Surveillance System (TESSy). EU/EEA countries are requested to report data every two weeks on Tuesdays. The data in the tracker are refreshed every two weeks on Thursdays at 11h after validation at ECDC level. Considering this reporting timeframe and the time ECDC needs to process the data, some discrepancies may be observed between the figures published by ECDC and the ones presented in official national reports or web sites. Users are advised to use all data with caution and be aware of their limitations. Data for the current week are preliminary, as countries may be uploading only partial data. All data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed. Please refer to the "Notes on the data" tab for additional information. Total doses distributed to EU/EEA countries 29 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden Total doses administered in EU/EEA countries 30 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden Indicator: Product: EU EU/EEA NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES PER HUNDRED INHABITANTS These graphs present the total number of vaccine doses distributed by manufacturers to EU/EEA countries divided by the size of the total population in each country. Population denominators for the total population are obtained from Eurostat/UN. NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES BY VACCINE PRODUCT These graphs present the total number of vaccine doses distributed by manufacturers to EU/EEA countries by vaccine products. NUMBER OF VACCINE DOSES ADMINISTERED IN EU/EEA COUNTRIES BY VACCINE PRODUCT These graphs present the total number of vaccine doses administered in EU/EEA countries to the total population by vaccine products. BIVALENT VACCINES Vaccine doses labelled as “Comirnaty bivalent” include doses of both Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Vaccine doses labelled as “Spikevax bivalent” include doses of both Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Detailed data on doses administered for specific bivalent vaccines may be accessed in the Open data files. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES BY VACCINE PRODUCT These graphs present the number of vaccine doses distributed by manufacturers to EU/EEA countries by vaccine products. It may be displayed as cumulative or weekly. PROPORTION OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES BY VACCINE PRODUCT This figure shows the proportion of vaccines doses distributed by manufacturers to EU/EEA countries by vaccine product out of the total number of doses supplied to each country. NUMBER OF VACCINE DOSES ADMINISTERED IN EU/EEA COUNTRIES BY VACCINE PRODUCT These graphs present the number of vaccine doses administered in EU/EEA countries by vaccine products. It may be displayed as cumulative or weekly. BIVALENT VACCINES Vaccine doses labelled as “Comirnaty bivalent” include doses of both Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Vaccine doses labelled as “Spikevax bivalent” include doses of both Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Detailed data on doses administered for specific bivalent vaccines may be accessed in the Open data files. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. TOTAL NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES BY VACCINE PRODUCT This graph displays the total number of vaccine doses distributed by manufacturers to EU/EEA countries by vaccine products. TOTAL NUMBER OF VACCINE DOSES ADMINISTERED IN EU/EEA COUNTRIES BY VACCINE PRODUCT This graph displays the total number of vaccine administered in EU/EEA countries by vaccine products. BIVALENT VACCINES Vaccine doses labelled as “Comirnaty bivalent” include doses of both Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Vaccine doses labelled as “Spikevax bivalent” include doses of both Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Detailed data on doses administered for specific bivalent vaccines may be accessed in the Open data files. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. TOTAL NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES BY VACCINE PRODUCT This graph displays the total number of vaccine doses distributed by manufacturers to EU/EEA countries by vaccine products. TOTAL NUMBER OF VACCINE DOSES ADMINISTERED IN EU/EEA COUNTRIES BY VACCINE PRODUCT This graph displays the total number of vaccine doses administered in EU/EEA countries by vaccine products. BIVALENT VACCINES Vaccine doses labelled as “Comirnaty bivalent” include doses of both Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Vaccine doses labelled as “Spikevax bivalent” include doses of both Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Detailed data on doses administered for specific bivalent vaccines may be accessed in the Open data files. Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation. Please refer to the Notes on the data tab to export the full data set. Please refer to the notes on the data tab for additional information on the data Data as of 2022-11-17 GENERAL INFORMATION The ECDC Vaccine tracker provides an overview of the progress in the rollout of COVID-19 vaccines in the EU/EEA. It presents detailed information on the number of vaccine doses distributed by manufacturers to each country for the different vaccines in use in the EU and the number of doses, primary courses and booster doses administered to adult individuals (18+), the total population and by age groups, including below 18 years of age. The total population includes children for whom the vaccine is not yet indicated or who may not yet be included in national target groups. A weekly COVID-19 Country Overview report is also published every week on Thursdays with updated information on the COVID-19 vaccine rollout in the EU/EEA. As a general disclaimer, data should be interpreted with caution, including comparisons across countries. For their correct interpretation, all possible factors affecting vaccine deployment in each country should be considered, as well as data completeness and quality. Data quality is consistently monitored and discussed with countries. Data may be retrospectively corrected. COVID-19 VACCINE DATA The data presented in the Vaccine Tracker are collected through The European Surveillance System (TESSy). EU/EEA countries report weekly aggregated data on number of vaccine doses distributed by manufacturers to the country, number of first, second, booster and unspecified doses administered to adolescents and children below 18 years of age, adult population (18+) and by age group. Vaccine doses administered to individuals below 18 years currently mostly include doses administered to individuals in the age range of 5 to 17 years, and to a lesser extent doses administered “off label” to children below 5 years with vulnerabilities. The number of doses distributed by the manufacturers is calculated based on the number of doses per vial defined for each specific vaccine in the product information available on the EMA website. It is not currently possible to differentiate additional doses administered as extension of the primary course in certain population groups (e.g. in immunocompromised individuals) and boosters. For surveillance purpose the following definitions are used for the data presented in the vaccine tracker. “First booster” refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals. “Second booster” refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course. EU/EEA countries are requested to report data every two weeks on Tuesdays. The data in the vaccine tracker are refreshed every two weeks on Thursdays at 11h after validation at ECDC level. Considering this reporting timeframe and the time ECDC needs to process the data, some discrepancies may be observed between the figures published by ECDC and the ones presented in official national reports or web sites. At country level different systems to monitor the vaccine roll out may be in place (see links to national data on the COVID-19 vaccine rollout in the "Country Profiles" tab). The cumulative vaccine uptake is expressed as a percentage and calculated as follows: number of vaccine doses cumulatively administered divided by the size of the corresponding population. Uptakes are calculated separately for at least one dose, a complete primary course and booster doses. Primary course is defined according to the schedule included in the Summary of Product Characteristics for each vaccine product as authorised by EMA. Population denominators for the total population, adult population and detailed age groups are obtained from Eurostat/UN. As of 28 April 2022, new Eurostat/UN population estimates for 2021 are used for the denominators of the total population, adults and detailed age groups. For some countries, the estimated cumulative vaccine uptake in certain age groups may exceed 100%. These data should be interpreted with caution and, when available, explanatory notes are included in the Country Disclaimers below. DATA COMPLETENESS COUNTRY DISCLAIMERS OPEN DATA * COVID-19 data collection * Open Data COVID-19 * Open data Vaccine tracker * Open data metadata rules * Legal notice * Copyright * Access to TESSy data * Personal data protection * Language policy * Cookie policy Vaccine tracker v6.1 HELP HOW TO EXPAND A WIDGET By clicking on this icon you will be able to expand the widget. By clicking on this similar icon, the widget will go back to its original size. -------------------------------------------------------------------------------- HOW TO CREATE SELECTIONS TO A VIEW By clicking on the different items in this menu, you are able to create selections in your view. You are able to search or type in the listbox of each component and select settings. You will see different buttons in the box that shows up. You can set different settings to your selection. To close the box. To confirm the settings that you would like to see. -------------------------------------------------------------------------------- HOW TO GO BACK TO A PREVIOUS VIEW On the top of the page you will find a menu. By clicking on Current selections, you are able to scroll through a list of previous selections and go back to an older view. HOW TO RESET THE SELECTIONS OF YOUR VIEW On the top of the page you will find a menu. By clicking on Reset selections you are able to reset the selection. HOW TO UNDO THE SELECTIONS OF YOUR VIEW On the top of the page you will find a menu. By clicking on Undo selections you are able to undo the selection. HOW TO REDO THE SELECTIONS OF YOUR VIEW On the top of the page you will find a menu. By clicking on Redo selections you are able to redo the selection. -------------------------------------------------------------------------------- HOW TO EXPORT AND VIEW CHART OR DATA When you hover over a widget, a new button will appear: By clicking on this button, two options will appear To export data. You will get the option to export the data, to export it as an image or to a PDF. To choose if you want to view a chart or the data. The button will change according to what you choose -------------------------------------------------------------------------------- HOW TO ZOOM IN ON A GRAPH By scrolling with your mouse over a graph, you can zoom in on a few days in a graph, up till one specific day. -------------------------------------------------------------------------------- Version 6.1 © European Centre for Disease Prevention and Control (ECDC) 2021 EXPORT DATA × Format CSV XML JSON Close Export Loading... CREATE BOOKMARK × Title Description Close Create EXPORT × Export data Export as an image Image size Default Custom Width (pixels) Height (pixels) File type Png Jpeg Paper size A3 A4 A5 A6 A7 Custom Width (mm) Height (mm) Orientation Portrait Landscape Aspect ratio Default size Fit to page Width (pixels) Height (pixels) Close Export Loading... × Close 😕 WE MISS YOU... × Your session has expired due to inactivity. Please refresh the page to reconnect. Refresh